Intensity-modulated radiotherapy for relapsed malignant pleural mesothelioma

Future Oncol. 2016 Dec;12(23s):67-71. doi: 10.2217/fon-2016-0330. Epub 2016 Sep 21.

Abstract

The use of novel radiotherapy techniques is widely increasing, allowing clinicians to treat diseases that were previously difficult to treat with radiation therapy. Malignant pleural mesothelioma is a clear example of this clinical challenge. We describe our first experience with intensity-modulated radiotherapy technique which was used to treat a 73-year-old patient with multiple relapsing malignant pleural mesothelioma. Intensity-modulated radiation therapy has allowed to respect the QUANTEC (quantitative analyses of normal tissue effects in the clinic) dose constraints, patient has experienced a 14 months progression-free time, without relevant subacute or late lung toxicity.

Keywords: IMRT; malignant pleural mesothelioma; radiation therapy.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Fluorodeoxyglucose F18
  • Humans
  • Lung Neoplasms / diagnosis*
  • Lung Neoplasms / radiotherapy*
  • Male
  • Mesothelioma / diagnosis*
  • Mesothelioma / radiotherapy*
  • Mesothelioma, Malignant
  • Neoplasm Recurrence, Local
  • Pleural Neoplasms / diagnosis*
  • Pleural Neoplasms / radiotherapy*
  • Positron Emission Tomography Computed Tomography
  • Radiotherapy Dosage
  • Radiotherapy Planning, Computer-Assisted
  • Radiotherapy, Intensity-Modulated* / adverse effects
  • Radiotherapy, Intensity-Modulated* / methods
  • Treatment Outcome
  • Tumor Burden

Substances

  • Fluorodeoxyglucose F18